In terms of market performance, CRISPR Therapeutics AG had a fairly uneven. The highest value for the stock in the past year was $91.10 on 02/22/24, and the lowest value was recorded at $43.42 on 09/06/24.
52-week price history of CRSP Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. CRISPR Therapeutics AG’s current trading price is -50.16% away from its 52-week high, while its distance from the 52-week low is 4.56%. The stock’s price range during this period has spanned from $43.42 to $91.10. In the Healthcare sector, the CRISPR Therapeutics AG’s shares surpassed a trading volume of approximately 1.97 million for the day, which was noticeably higher compared to the average daily volume of 9.1.46 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
CRISPR Therapeutics AG (CRSP) has experienced a quarterly decline of -7.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.88B and boasts a workforce of 407 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 48.77, with a change in price of -11.79. Similarly, CRISPR Therapeutics AG recorded 1,341,775 in trading volume during the last 100 days, posting a change of -20.62%.
Examining CRSP’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CRSP stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.11.
CRSP Stock Stochastic Average
Today’s raw stochastic average for CRISPR Therapeutics AG over the last 50 days is 6.56%.This indicates a increase from the raw stochastic average of the past 20 days, which was 0.10%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 18.18% and 28.32%, respectively.
CRSP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -27.48% this year. Over the last six months, there has been a stronger performance of -30.43%. The price of CRSP leaped by -10.51% during the last 30 days period. For the last 5-days stocks have slided -8.30%.
